Group One Trading
DSGN icon

Group One Trading’s Design Therapeutics DSGN Stock Holding History

Group One Trading’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13K Buy
+200
New +$2.02K ﹤0.01% 7034
2024
Q2 		– Sell
-500
Closed -$2.02K – 6884
2024
Q1 		$2.02K Sell
500
-1,000
-67% -$2.67K ﹤0.01% 6489
2023
Q4 		$3.98K Sell
1,500
-1,700
-53% -$3.89K ﹤0.01% 6595
2023
Q3 		$7.55K Buy
3,200
+2,500
+357% +$11.7K ﹤0.01% 6502
2023
Q2 		$4.41K Buy
+700
New +$4.28K ﹤0.01% 6773
2023
Q1 		– Sell
-1,900
Closed -$19.5K – 7368
2022
Q4 		$19.5K Buy
+1,900
New +$25.7K ﹤0.01% 5613

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's DSGN Position: Q4 2024 in Review

Group One Trading sold out of Design Therapeutics (DSGN) in Q4 2024, closing a stake of 1,000 shares — an estimated $5.38K sold.

Group One Trading first reported a position in DSGN in Q4 2022 and held it in 5 quarters. The position peaked at $5.38K in Q3 2024. 95 funds tracked by Wall St. Rank hold DSGN as of Q4 2024.

  • Group One Trading reported no remaining Design Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 1,000 Design Therapeutics shares in Q4 2024, an estimated $5.38K.
  • Group One Trading first reported a position in Design Therapeutics in Q4 2022 and held it in 5 quarters.
  • Group One Trading's Design Therapeutics position peaked at $5.38K in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Design Therapeutics as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.